Phase III Analyses Prompt Partial Clinical Hold On Oncopeptides' Melflufen Studies

OCEAN OS Data Favors Active Comparator

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.